Stay updated on Acalabrutinib Pembrolizumab Combo in Head & Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the Acalabrutinib Pembrolizumab Combo in Head & Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Acalabrutinib Pembrolizumab Combo in Head & Neck Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.0 to v3.7.1 while the page continued to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T18:49:31.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the study record details and related navigation with an error screen.
    Difference
    17%
    Check dated 2026-09-19T19:12:49.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    The page revision tag changed from v3.6.5 to v3.6.6. This reflects a version update to the study details page on ClinicalTrials.gov.
    Difference
    0.1%
    Check dated 2026-08-29T21:56:35.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    An updated page revision is shown: 'Revision: v3.6.5' replaces 'Revision: v3.6.4', reflecting a newer version of the page/templating for the study details.
    Difference
    0.1%
    Check dated 2026-08-08T17:34:39.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    The revision label on the page updated from v3.6.3 to v3.6.4, indicating a newer build of the study details page. This change does not modify study details or user-facing functionality.
    Difference
    0.1%
    Check dated 2026-07-25T10:22:03.000Z thumbnail image
  8. Check
    104 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.2 to v3.6.3, indicating a new site version. The change appears to be a backend/software update without altering study content or user actions.
    Difference
    0.1%
    Check dated 2026-07-03T22:36:04.000Z thumbnail image

Stay in the know with updates to Acalabrutinib Pembrolizumab Combo in Head & Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Acalabrutinib Pembrolizumab Combo in Head & Neck Cancer Clinical Trial page.